Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies Rebecca A. Marsh, MD, Kyle M. Hebert, MS, Daniel Keesler, BS, Jaap J. Boelens, MD, PhD, Christopher C. Dvorak, MD, Michael J. Eckrich, MD, MPH, Neena Kapoor, MD, Suhag Parikh, MD, Mary Eapen, MD Journal of Allergy and Clinical Immunology Volume 142, Issue 6, Pages 2004-2007 (December 2018) DOI: 10.1016/j.jaci.2018.08.010 Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 1 Three-year overall survival for patients with SCID by time period (A), patients without SCID by time period (B), patients with SCID by time period and by newborn screening diagnosis or not in the time period 2010 to 2016 (C), and patients without SCID by diagnosis group in the time period 2010 to 2016 (D). CGD, Chronic granulomatous disease; CH, Chediak-Higashi syndrome; HLH, hemophagocytic lymphohistiocytosis; XLP, X-linked lymphoproliferative disease. Journal of Allergy and Clinical Immunology 2018 142, 2004-2007DOI: (10.1016/j.jaci.2018.08.010) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions